These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 11136695)

  • 1. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.
    Feron O; Dessy C; Desager JP; Balligand JL
    Circulation; 2001 Jan; 103(1):113-8. PubMed ID: 11136695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.
    Brouet A; Sonveaux P; Dessy C; Moniotte S; Balligand JL; Feron O
    Circ Res; 2001 Nov; 89(10):866-73. PubMed ID: 11701613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase.
    Feron O; Dessy C; Moniotte S; Desager JP; Balligand JL
    J Clin Invest; 1999 Mar; 103(6):897-905. PubMed ID: 10079111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
    Hernández-Perera O; Pérez-Sala D; Navarro-Antolín J; Sánchez-Pascuala R; Hernández G; Díaz C; Lamas S
    J Clin Invest; 1998 Jun; 101(12):2711-9. PubMed ID: 9637705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native low-density lipoprotein induces endothelial nitric oxide synthase dysfunction: role of heat shock protein 90 and caveolin-1.
    Pritchard KA; Ackerman AW; Ou J; Curtis M; Smalley DM; Fontana JT; Stemerman MB; Sessa WC
    Free Radic Biol Med; 2002 Jul; 33(1):52-62. PubMed ID: 12086682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cracking down on caveolin: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in modulating edothelial cell nitric oxide production.
    Davis ME; Harrison DG
    Circulation; 2001 Jan; 103(1):2-4. PubMed ID: 11136674
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
    Wagner AH; Köhler T; Rückschloss U; Just I; Hecker M
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.
    Suh JW; Choi DJ; Chang HJ; Cho YS; Youn TJ; Chae IH; Kim KI; Kim CH; Kim HS; Oh BH; Park YB
    J Korean Med Sci; 2010 Jan; 25(1):16-23. PubMed ID: 20052342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse balance of nitric oxide/peroxynitrite in the dysfunctional endothelium can be reversed by statins.
    Heeba G; Hassan MK; Khalifa M; Malinski T
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):391-8. PubMed ID: 18049306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.
    Beckman JA; Liao JK; Hurley S; Garrett LA; Chui D; Mitra D; Creager MA
    Circ Res; 2004 Jul; 95(2):217-23. PubMed ID: 15178637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of LOX-1 by statins may relate to upregulation of eNOS.
    Mehta JL; Li DY; Chen HJ; Joseph J; Romeo F
    Biochem Biophys Res Commun; 2001 Dec; 289(4):857-61. PubMed ID: 11735125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
    Wagner AH; Schwabe O; Hecker M
    Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice.
    Laufs U; Gertz K; Huang P; Nickenig G; Böhm M; Dirnagl U; Endres M
    Stroke; 2000 Oct; 31(10):2442-9. PubMed ID: 11022078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH; Gebauer M; Güldenzoph B; Hecker M
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low density lipoprotein induces eNOS translocation to membrane caveolae: the role of RhoA activation and stress fiber formation.
    Zhu Y; Liao HL; Niu XL; Yuan Y; Lin T; Verna L; Stemerman MB
    Biochim Biophys Acta; 2003 Dec; 1635(2-3):117-26. PubMed ID: 14729074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp90 ensures the transition from the early Ca2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells.
    Brouet A; Sonveaux P; Dessy C; Balligand JL; Feron O
    J Biol Chem; 2001 Aug; 276(35):32663-9. PubMed ID: 11425855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme a reductase in vascular endothelial cells: a mechanism for development of atherosclerosis?
    Li H; Lewis A; Brodsky S; Rieger R; Iden C; Goligorsky MS
    Circulation; 2002 Mar; 105(9):1037-43. PubMed ID: 11877351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells.
    Kolyada AY; Fedtsov A; Madias NE
    Hypertension; 2001 Nov; 38(5):1024-9. PubMed ID: 11711492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins.
    Igarashi J; Miyoshi M; Hashimoto T; Kubota Y; Kosaka H
    Br J Pharmacol; 2007 Feb; 150(4):470-9. PubMed ID: 17220911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: balance between transcriptional and posttranscriptional regulation.
    Martínez-González J; Raposo B; Rodríguez C; Badimon L
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):804-9. PubMed ID: 11348878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.